• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于羟肟酸衍生物的药效团模型构建和电子特性分析,作为 HIV 整合酶抑制剂。

Pharmacophore modelling and electronic feature analysis of hydroxamic acid derivatives, the HIV integrase inhibitors.

机构信息

Centre for Bioinformatics, School of Life Sciences, Pondicherry University, Puducherry, India.

出版信息

SAR QSAR Environ Res. 2013;24(9):753-71. doi: 10.1080/1062936X.2013.792870. Epub 2013 May 28.

DOI:10.1080/1062936X.2013.792870
PMID:23710969
Abstract

Hydroxamic acid derivatives with metal ion binding properties were collected from the literature to generate a pharmacophore and 3D-QSAR model for HIV strand transfer inhibition. The derived pharmacophore model (AAAHRR) recognizes both metal ion binding site and hydrophobic group. The QSAR model generated using this hypothesis expressed statistical significance (r(2) = 0.971 for the training set and q(2) = 0.913 for the test set). The ability of this pharmacophore model to retrieve other metal ion binding inhibitors was examined by screening the ChemBank database (ligandinfo) incorporated with 10 known strand transfer inhibitors. The studied favourable and unfavourable contours of chemical features (H-bond donor, acceptor and hydrophobic sites) revealed the role of hydrophobic substitution at the fluorobenzene ring and cyclization of the metal ion binding hydroxamic acid in effective integrase inhibition. Analysis of the frontier orbitals, HOMO and LUMO revealed that the nucleophilic / electrophilic interactions depend on the significant overlapping observed at the azaindole and hydroxamic acid groups. In essence, the generated pharmacophore model is competent enough to disclose the essential site-specific interactions involved in the inhibition of HIV integrase, and hence can be used in virtual screening to identify novel scaffolds as leads with increased anti-viral potency.

摘要

收集了具有金属离子结合特性的羟肟酸衍生物,用于生成 HIV 链转移抑制的药效团和 3D-QSAR 模型。推导的药效团模型(AAAHRR)识别金属离子结合位点和疏水区。使用该假设生成的 QSAR 模型在统计学上具有显著意义(训练集的 r(2) = 0.971,测试集的 q(2) = 0.913)。通过筛选包含 10 种已知链转移抑制剂的 ChemBank 数据库(ligandinfo),检查了该药效团模型检索其他金属离子结合抑制剂的能力。研究了有利和不利的化学特征(氢键供体、受体和疏水部位)轮廓,揭示了氟苯环上的疏水性取代和金属离子结合羟肟酸的环化在有效整合酶抑制中的作用。前线轨道、HOMO 和 LUMO 的分析表明,亲核/亲电相互作用取决于在氮茚和羟肟酸基团中观察到的显著重叠。从本质上讲,生成的药效团模型足以揭示 HIV 整合酶抑制中涉及的关键特定相互作用,因此可用于虚拟筛选,以确定具有更高抗病毒活性的新型支架作为先导物。

相似文献

1
Pharmacophore modelling and electronic feature analysis of hydroxamic acid derivatives, the HIV integrase inhibitors.基于羟肟酸衍生物的药效团模型构建和电子特性分析,作为 HIV 整合酶抑制剂。
SAR QSAR Environ Res. 2013;24(9):753-71. doi: 10.1080/1062936X.2013.792870. Epub 2013 May 28.
2
Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.基于药效团模型和原子的 N-甲基嘧啶酮类 HIV-1 整合酶抑制剂的 3D-QSAR 研究。
J Enzyme Inhib Med Chem. 2012 Jun;27(3):339-47. doi: 10.3109/14756366.2011.590803. Epub 2011 Jun 24.
3
Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.基于药效团的HIV-1整合酶链转移抑制剂设计
J Med Chem. 2005 Nov 3;48(22):7084-8. doi: 10.1021/jm050549e.
4
Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.氮杂吲哚异羟肟酸是有效的HIV-1整合酶抑制剂。
J Med Chem. 2009 Nov 26;52(22):7211-9. doi: 10.1021/jm900862n.
5
Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.基于配体和结构的HIV-1整合酶链转移抑制剂联合方法。
Chem Biol Interact. 2014 Jul 25;218:71-81. doi: 10.1016/j.cbi.2014.04.011. Epub 2014 May 2.
6
Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.二酮酸药效基团。2. 人免疫缺陷病毒1型整合酶结构多样的抑制剂的发现。
J Med Chem. 2005 Dec 15;48(25):8009-15. doi: 10.1021/jm050837a.
7
Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.β-二酮酸药效团假说。1. 一类新型HIV-1整合酶抑制剂的发现。
J Med Chem. 2005 Jan 13;48(1):111-20. doi: 10.1021/jm0496077.
8
HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching.HIV-1整合酶药效团:通过三维数据库搜索发现抑制剂
J Med Chem. 1997 Mar 14;40(6):920-9. doi: 10.1021/jm960596u.
9
Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.二羟基噻吩是一类具有二酮酸样药效基团的新型高效人类免疫缺陷病毒整合酶抑制剂。
J Virol. 2006 Jul;80(14):6883-94. doi: 10.1128/JVI.00306-06.
10
Pharmacophore development and docking studies of the hiv-1 integrase inhibitors derived from N-methylpyrimidones, Dihydroxypyrimidines, and bicyclic pyrimidinones.基于 N-甲基嘧啶酮、二羟嘧啶和双环嘧啶酮的 HIV-1 整合酶抑制剂的药效团开发和对接研究。
Chem Biol Drug Des. 2011 Jul;78(1):150-60. doi: 10.1111/j.1747-0285.2011.01130.x. Epub 2011 May 25.

引用本文的文献

1
The dynamics of interconverting D- and E-forms of the HIV-1 integrase N-terminal domain.HIV-1整合酶N端结构域D型和E型相互转换的动力学
Eur Biophys J. 2014 Nov;43(10-11):485-98. doi: 10.1007/s00249-014-0979-4. Epub 2014 Aug 9.
2
Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants.含双环 1-羟基-2-氧代-1,2-二氢吡啶-3-甲酰胺的 HIV-1 整合酶抑制剂,对携带拉替拉韦耐药整合酶突变体的细胞具有高抗病毒活性。
J Med Chem. 2014 Feb 27;57(4):1573-82. doi: 10.1021/jm401902n. Epub 2014 Feb 10.